To include your compound in the COVID-19 Resource Center, submit it here.

Inflammation; infectious disease

INDICATION: Inflammatory disease; sepsis

In vitro and mouse studies suggest inhibiting the MAC-1-CD40L interaction could help treat systemic inflammatory response syndrome

Read the full 206 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE